Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Management
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week

Latest news

Group By Ticker
Sort By
Newest | Oldest
Read More
1 minute read
  • FDA
  • General
  • Government
  • Health Care
  • Large Cap
  • News
  • Regulations

Republicans Seek Documents, Schedule Hearing Related To FDA’s Response To Baby-Formula Shortage

By Vandana Singh
March 21, 3:37 PM
House Republicans are reportedly speeding up their scrutiny of the FDA and the White House's handling of the baby formula shortage last year.

ABT

Read More
1 minute read
  • Biotech
  • General
  • News

FDA Issues Letters Of Acknowledgement For Infant Formula Transition Plan

By Benzinga Newsdesk
January 9, 12:38 PM
- Reuters

ABT

Read More
1 minute read
  • News

Baby Formula Imports To Face Tariffs Again In 2023

By Benzinga Newsdesk
December 28, 10:11 AM
- WSJ

ABT

Read More
14 minute read
  • Options

Stocks That Hit 52-Week Lows On Thursday

By Benzinga Insights
December 15, 12:19 PM
  On Thursday, 241 companies hit new 52-week lows.

ACHL

Read More
7 minute read
  • Markets
  • Movers
  • News
  • Penny Stocks
  • Pre-Market Outlook
  • Small Cap
  • Trading Ideas

Why Party City Holdco Shares Tumbled Over 40%; Here Are 98 Biggest Movers From Yesterday

By Lisa Levin
November 9, 6:08 AM
Gainers Unique Fabricating, Inc. (NYSE: UFAB) jumped 56.3% to close at $0.8205 on Tuesday. Unique Fabricating posted a Q3 loss of $0.90 per share after the closing bell on Tuesday.

AAON

Read More
5 minute read
  • Intraday Update
  • Markets
  • Movers
  • News
  • Penny Stocks
  • Small Cap
  • Trading Ideas

Why TaskUs Shares Are Trading Higher By 37%? Here Are 77 Stocks Moving In Tuesday’s Mid-Day Session

By Lisa Levin
November 8, 1:51 PM
Gainers IceCure Medical Ltd (NASDAQ: ICCM) shares jumped 39.4% to $1.4529 after the company announced a payment assignment from the Centers for Medicare & Medicaid Services for the ProSense breast cancer cryoablation procedures.

AAON

Read More
1 minute read
  • Biotech
  • Earnings
  • General
  • Guidance
  • Health Care
  • Movers
  • News
  • Trading Ideas

Perrigo Shares Fall As Investors React To Lowered FY22 Profit Guidance

By Vandana Singh
November 8, 10:52 AM
Perrigo Company plc’s (NYSE: PRGO) Q3 FY22 sales increased 5.5% Y/Y or 12.3%, excluding the impact of currency translation to $1.10 billion,…

PRGO

Read More
21 minute read
  • Earnings

Earnings Scheduled For November 8, 2022

By Benzinga Insights
November 8, 5:32 AM
Companies Reporting Before The Bell • Adtran (NASDAQ:ADTN) is likely to report quarterly earnings at $0.18 per share on revenue of $330.39 million.

ABCL

Read More
1 minute read
  • FDA
  • General
  • Health Care
  • News

FDA Postpones Review Meeting For First OTC Contraceptive Option From Perrigo

By Vandana Singh
October 26, 1:34 PM
The FDA has pushed back a decision date on a proposed over-the-counter pill, Opill, from Perrigo Company plc’s (NYSE:PRGO) subsidiary, HRA Pharma.…

PRGO

Read More
1 minute read
  • FDA
  • News

FDA Says Report Highlights Findings And Recommendations That Will Support Agency’s Ongoing Efforts To Ensure Our Most Vulnerable Population Has Consistent Access To Infant And Specialty Formula Products In Future

By Benzinga Newsdesk
September 20, 3:26 PM
-Dow Jones

ABT

Posts navigation

1 2 … 7 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service